产前双侧严重脑室扩大中外显子组测序的诊断率:系统综述与Meta分析
该系统综述与Meta分析检索截至2022年6月,纳入28项研究共1988例产前外显子组测序分析(染色体微阵列分析阴性后),其中双侧严重脑室扩大138例;13项研究(117例)纳入合成分析,总体阳性诊断率为45%(95%CI 30-60)。非孤立性病例诊断率最高54%(95%CI 38-69),其次为伴其他颅脑异常38%(95%CI 22-57)和孤立性严重脑室扩大35%(95%CI 18-58)。作者认为在染色体微阵列分析阴性后,外显子组测序对双侧严重脑室扩大有增量诊断价值,孤立性病例也可考虑进行检测。
要点
- 染色体微阵列分析阴性后,外显子组测序在双侧严重脑室扩大中的总体阳性诊断率为45%(95%CI 30-60)。
- 非孤立性严重脑室扩大诊断率最高(54%,95%CI 38-69),高于伴其他颅脑异常(38%)和孤立性(35%)。
- 作者认为孤立性严重脑室扩大作为产前影像唯一脑异常时,也应考虑进行外显子组测序。
核心结论
- 染色体微阵列分析阴性后,产前外显子组测序在双侧严重脑室扩大中呈现增量诊断率。
- 非孤立性严重脑室扩大诊断率最高,但孤立性严重脑室扩大作为产前影像唯一脑异常时也应考虑外显子组测序。
研究设计与样本
- 系统综述与Meta分析,检索Cochrane Library、Web of Science、Scopus和MEDLINE至2022年6月,纳入报告染色体微阵列分析阴性后外显子组测序诊断率的英文研究。
- 共28项研究包含1988例产前外显子组测序分析,其中双侧严重脑室扩大138例;合成Meta分析纳入13项报告≥3例严重脑室扩大的研究,共117例。
- 联系队列研究作者获取个体参与者数据,2项研究提供了扩展队列数据;采用随机效应模型进行比例Meta分析,使用改良STARD标准进行质量评价。
- 系统综述部分未限制严重脑室扩大的最小病例数,合成Meta分析仅纳入≥3例严重脑室扩大的研究。
主要发现
- 在纳入分析的病例中,45%(95%CI 30-60)的外显子组测序结果为致病性/可能致病性阳性。
- 非孤立性严重脑室扩大(伴颅外异常)诊断率为54%(95%CI 38-69)。
- 伴其他颅脑异常的严重脑室扩大诊断率为38%(95%CI 22-57)。
- 孤立性严重脑室扩大(作为唯一颅脑异常)诊断率为35%(95%CI 18-58)。
- 共分类了47个基因中的59个遗传变异与产前严重脑室扩大相关,并附完整表型描述。
关键数值与推荐
- 外显子组测序阳性结果定义为致病性/可能致病性变异。
- 非孤立性严重脑室扩大:存在颅外异常。
- 孤立性严重脑室扩大:作为唯一颅脑异常。
- 伴其他颅脑异常的严重脑室扩大:存在其他颅脑异常。
临床怎么用
- 作者认为,在染色体微阵列分析阴性后,双侧严重脑室扩大病例可考虑进行产前外显子组测序。
- 作者认为,非孤立性严重脑室扩大诊断率最高,但孤立性严重脑室扩大作为产前影像唯一脑异常时也应考虑外显子组测序。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to determine the incremental diagnostic yield of prenatal exome sequencing after negative chromosomal microarray analysis results in prenatally diagnosed bilateral severe ventriculomegaly or hydrocephalus; another objective was to categorize the associated genes and variants. DATA SOURCES: A systematic search was performed to identify relevant studies published until June 2022 using 4 databases (Cochrane Library, Web of Science, Scopus, and MEDLINE). STUDY ELIGIBILITY CRITERIA: Studies in English reporting on the diagnostic yield of exome sequencing following negative chromosomal microarray analysis results in cases of prenatally diagnosed bilateral severe ventriculomegaly were included. METHODS: Authors of cohort studies were contacted for individual participant data, and 2 studies provided their extended cohort data. The incremental diagnostic yield of exome sequencing was assessed for pathogenic/likely pathogenic findings in cases of: (1) all severe ventriculomegaly; (2) isolated severe ventriculomegaly (as the only cranial anomaly); (3) severe ventriculomegaly with other cranial anomalies; and (4) nonisolated severe ventriculomegaly (with extracranial anomalies). To be able to identify all reported genetic associations, the systematic review portion was not limited to any minimal severe ventriculomegaly case numbers; however, for the synthetic meta-analysis, we included studies with ≥3 severe ventriculomegaly cases. Meta-analysis of proportions was done using a random-effects model. Quality assessment of the included studies was performed using the modified STARD (Standards for Reporting of Diagnostic Accuracy Studies) criteria. RESULTS: A total of 28 studies had 1988 prenatal exome sequencing analyses performed following negative chromosomal microarray analysis results for various prenatal phenotypes; this included 138 cases with prenatal bilateral severe ventriculomegaly. We categorized 59 genetic variants in 47 genes associated with prenatal severe ventriculomegaly along with their full phenotypic description. There were 13 studies reporting on ≥3 severe ventriculomegaly cases, encompassing 117 severe ventriculomegaly cases that were included in the synthetic analysis. Of all the included cases, 45% (95% confidence interval, 30-60) had positive pathogenic/likely pathogenic exome sequencing results. The highest yield was for nonisolated cases (presence of extracranial anomalies; 54%; 95% confidence interval, 38-69), followed by severe ventriculomegaly with other cranial anomalies (38%; 95% confidence interval, 22-57) and isolated severe ventriculomegaly (35%; 95% confidence interval, 18-58). CONCLUSION: There is an apparent incremental diagnostic yield of prenatal exome sequencing following negative chromosomal microarray analysis results in bilateral severe ventriculomegaly. Although the greatest yield was found in cases of nonisolated severe ventriculomegaly, consideration should also be given to performing exome sequencing in cases of isolated severe ventriculomegaly as the only brain anomaly identified on prenatal imaging.
引用
- Mustafa HJ, Sambatur EV, Barbera JP, et al. Diagnostic yield with exome sequencing in prenatal severe bilateral ventriculomegaly: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37311485. doi:10.1016/j.ajogmf.2023.101048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。